Relapsed/refractory marginal zone lymphoma (r/r mzl) Clinical Trials
Conditions / Relapsed/refractory marginal zone lymphoma (r/r mzl)
Delta Trials catalogs 1 clinical trial for Relapsed/refractory marginal zone lymphoma (r/r mzl) in its publicly accessible dataset. Within this set, 1 currently recruiting participants and 0 trials have reached completion. This research occurs across 141 participating sites around the world. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
141
Study Locations
Browse by location (141 total)
- Busan, South Korea 1 trialAll trials in Busan, South Korea
- Uxbridge, United Kingdom 1 trialAll trials in Uxbridge, United Kingdom
- Ulsan, South Korea 1 trialAll trials in Ulsan, South Korea
- Katowice, Poland 1 trialAll trials in Katowice, Poland
- Jaú, Brazil 1 trialAll trials in Jaú, Brazil
- Jaú, Brazil 1 trialAll trials in Jaú, Brazil
- Jaú, Brazil 1 trialAll trials in Jaú, Brazil
- Taoyuan, Taiwan 1 trialAll trials in Taoyuan, Taiwan
- Los Angeles, United States 1 trialAll trials in Los Angeles, United States
- Kuala Lumpur, Malaysia 1 trialAll trials in Kuala Lumpur, Malaysia
- Genoa, Italy 1 trialAll trials in Genoa, Italy
- Jerusalem, Israel 1 trialAll trials in Jerusalem, Israel
- Samsun, Turkey (türkiye) 1 trialAll trials in Samsun, Turkey (türkiye)
- Westbury, United States 1 trialAll trials in Westbury, United States
- Palma, Spain 1 trialAll trials in Palma, Spain
- Lublin, Poland 1 trialAll trials in Lublin, Poland
- Mezitli, Turkey (türkiye) 1 trialAll trials in Mezitli, Turkey (türkiye)
- Stuttgart, Germany 1 trialAll trials in Stuttgart, Germany
- Great Yarmouth, United Kingdom 1 trialAll trials in Great Yarmouth, United Kingdom
- Skorzewo, Poland 1 trialAll trials in Skorzewo, Poland